Difficulty: Medium
Average Score: 95%
Practice
What percentage (%) of patients with rheumatic mitral valve disease has the echocardiographic diagnosis of tricuspid stenosis as a co-existing lesion?
Correct answer
A
Rationale
In the context of pediatric cardiovascular conditions, understanding the prevalence of co-existing lesions in rheumatic mitral valve disease is crucial for effective patient management. The correct answer to the question is A) 10%. This percentage reflects the relatively lower frequency of tricuspid stenosis as a co-existing lesion in patients with rheumatic mitral valve disease.
Option B) 20%, C) 30%, and D) 40% are incorrect because they overestimate the prevalence of tricuspid stenosis in this specific population. By knowing the accurate percentage, healthcare providers can make informed decisions regarding diagnostic testing, treatment strategies, and monitoring protocols for pediatric patients with rheumatic mitral valve disease.
Educationally, this question highlights the importance of precision and accuracy in understanding epidemiological data related to cardiovascular conditions in pediatric patients. It emphasizes the need for healthcare providers to be well-versed in the nuances of disease presentations and co-morbidities to deliver optimal care to this vulnerable population. Understanding these statistics can guide clinical practice and improve patient outcomes by ensuring appropriate interventions are implemented based on evidence-based data.
Option B) 20%, C) 30%, and D) 40% are incorrect because they overestimate the prevalence of tricuspid stenosis in this specific population. By knowing the accurate percentage, healthcare providers can make informed decisions regarding diagnostic testing, treatment strategies, and monitoring protocols for pediatric patients with rheumatic mitral valve disease.
Educationally, this question highlights the importance of precision and accuracy in understanding epidemiological data related to cardiovascular conditions in pediatric patients. It emphasizes the need for healthcare providers to be well-versed in the nuances of disease presentations and co-morbidities to deliver optimal care to this vulnerable population. Understanding these statistics can guide clinical practice and improve patient outcomes by ensuring appropriate interventions are implemented based on evidence-based data.